These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31069424)

  • 1. Synergistic anticataleptic effect of imipramine and nicotine in a rotenone-induced rat model.
    Ionov ID; Pushinskaya II; Gorev NP; Shpilevaya LA
    Psychopharmacology (Berl); 2019 Nov; 236(11):3125-3133. PubMed ID: 31069424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticataleptic activity of nicotine in rats: involvement of the lateral entorhinal cortex.
    Ionov ID; Pushinskaya II; Gorev NP; Frenkel DD; Severtsev NN
    Psychopharmacology (Berl); 2021 Sep; 238(9):2471-2483. PubMed ID: 34002247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of glutamate and alpha2-noradrenergic receptor antagonists on the development of neurotoxicity produced by chronic rotenone in rats.
    Alam M; Danysz W; Schmidt WJ; Dekundy A
    Toxicol Appl Pharmacol; 2009 Oct; 240(2):198-207. PubMed ID: 19616571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine-Induced Neuroprotection in Rotenone In Vivo and In Vitro Models of Parkinson's Disease: Evidences for the Involvement of the Labile Iron Pool Level as the Underlying Mechanism.
    Mouhape C; Costa G; Ferreira M; Abin-Carriquiry JA; Dajas F; Prunell G
    Neurotox Res; 2019 Jan; 35(1):71-82. PubMed ID: 30006684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of L-thyroxin in counteracting rotenone induced neurotoxicity in rats.
    Salama M; Helmy B; El-Gamal M; Reda A; Ellaithy A; Tantawy D; Mohamed M; El-Gamal A; Sheashaa H; Sobh M
    Environ Toxicol Pharmacol; 2013 Mar; 35(2):270-7. PubMed ID: 23357603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ameliorative effect of Sida cordifolia in rotenone induced oxidative stress model of Parkinson's disease.
    Khurana N; Gajbhiye A
    Neurotoxicology; 2013 Dec; 39():57-64. PubMed ID: 23994302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticataleptic properties of alpha2 adrenergic antagonists in the crossed leg position and bar tests: differential mediation by 5-HT1A receptor activation.
    Kleven MS; Assié MB; Cosi C; Barret-Grévoz C; Newman-Tancredi A
    Psychopharmacology (Berl); 2005 Feb; 177(4):373-80. PubMed ID: 15448976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative importance of the dopaminergic system in haloperidol-catalepsy and the anticataleptic effect of antidepressants and methamphetamine in rats.
    Al-Khatib IM; Fujiwara M; Ueki S
    Pharmacol Biochem Behav; 1989 May; 33(1):93-7. PubMed ID: 2528750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neurobehavioral changes induced by bilateral rotenone lesion in medial forebrain bundle of rats are reversed by L-DOPA.
    Alam M; Mayerhofer A; Schmidt WJ
    Behav Brain Res; 2004 May; 151(1-2):117-24. PubMed ID: 15084427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of mitochondrial ATP-sensitive potassium channels improves rotenone-related motor and neurochemical alterations in rats.
    Yang Y; Liu X; Long Y; Wang F; Ding JH; Liu SY; Sun YH; Yao HH; Wang H; Wu J; Hu G
    Int J Neuropsychopharmacol; 2006 Feb; 9(1):51-61. PubMed ID: 15927086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic administration of iptakalim, an ATP-sensitive potassium channel opener, prevents rotenone-induced motor and neurochemical alterations in rats.
    Yang Y; Liu X; Long Y; Wang F; Ding JH; Liu SY; Sun YH; Yao HH; Wang H; Wu J; Hu G
    J Neurosci Res; 2005 May; 80(3):442-9. PubMed ID: 15795934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-DOPA reverses the hypokinetic behaviour and rigidity in rotenone-treated rats.
    Alam M; Schmidt WJ
    Behav Brain Res; 2004 Aug; 153(2):439-46. PubMed ID: 15265640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic low-dose melatonin treatment maintains nigrostriatal integrity in an intrastriatal rotenone model of Parkinson's disease.
    Carriere CH; Kang NH; Niles LP
    Brain Res; 2016 Feb; 1633():115-125. PubMed ID: 26740407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of metabotropic glutamate receptors in the mechanisms of experimental parkinsonism development.
    Bashkatova VG; Sudakov SK
    Bull Exp Biol Med; 2012 Sep; 153(5):655-7. PubMed ID: 23113249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of imipramine on the behavior and cerebral 5-HT1A serotonin receptors in mice genetically predisposed to catalepsy.
    Tikhonova MA; Lebedeva VV; Kulikov AV; Bazovkina DV; Popova NK
    Bull Exp Biol Med; 2006 Jan; 141(1):48-50. PubMed ID: 16929962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral alterations in rotenone model of Parkinson's disease: attenuation by co-treatment of centrophenoxine.
    Nehru B; Verma R; Khanna P; Sharma SK
    Brain Res; 2008 Mar; 1201():122-7. PubMed ID: 18308296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
    Saravanan KS; Sindhu KM; Senthilkumar KS; Mohanakumar KP
    Neurochem Int; 2006 Jul; 49(1):28-40. PubMed ID: 16490285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute intranigral infusion of rotenone in rats causes progressive biochemical lesions in the striatum similar to Parkinson's disease.
    Saravanan KS; Sindhu KM; Mohanakumar KP
    Brain Res; 2005 Jul; 1049(2):147-55. PubMed ID: 15936733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective Properties of Standardized Extracts of Hypericum perforatum on Rotenone Model of Parkinson's Disease.
    Gómez del Rio MA; Sánchez-Reus MI; Iglesias I; Pozo MA; García-Arencibia M; Fernández-Ruiz J; García-García L; Delgado M; Benedí J
    CNS Neurol Disord Drug Targets; 2013 Aug; 12(5):665-79. PubMed ID: 23469842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic administration of rotenone produces selective damage in the striatum and globus pallidus, but not in the substantia nigra.
    Ferrante RJ; Schulz JB; Kowall NW; Beal MF
    Brain Res; 1997 Apr; 753(1):157-62. PubMed ID: 9125443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.